Advertisement

Development of a Targeted Next-Generation Sequencing assay to Detect Diagnostically Relevant Mutations of JAK2, CALR, and MPL in Myeloproliferative Neoplasms

Researchers developed a next-generation sequencing assay to detect known MPN driver mutations JAK2, CALR, and MPL more quickly and efficiently than classical MPN mutation screening.

 Cancer Cell